Healthcare Email Marketing Compliance: HIPAA, CAN-SPAM, and the Content-Level Rules That Apply to Every Patient Email

Healthcare email marketing combines several regulatory layers: HIPAA rules on patient communication and use of PHI, CAN-SPAM rules on commercial email generally, FTC rules on claims in the email body, and state-specific email marketing rules. This post covers the full framework for HIPAA-compliant, FTC-compliant healthcare email marketing.

The HIPAA layer

HIPAA affects email marketing in several specific ways:

• Patient list usage. Using patient contact information for marketing is generally marketing under HIPAA and requires authorization, with some specific exceptions.
• Treatment communication exception.Communications about the patient’s own treatment are not marketing under HIPAA. But communications promoting other services often are.
• PHI in email content. Including PHI in email content (even to the patient whose PHI it is) has specific security considerations.
• Email security. Standard email is not secure. Using standard email for PHI requires specific patient consent.

The CAN-SPAM layer

CAN-SPAM applies to commercial emails. Key requirements:

• Accurate header information (not misleading sender/subject).
• Clear identification as advertising (if primary purpose is commercial).
• Physical mailing address.
• Clear and conspicuous opt-out mechanism.
• Processing opt-outs within 10 business days.

Most healthcare practice emails fall under CAN-SPAM when they include promotional content alongside any transactional content.

Content rules in email

Email body content is marketing subject to the same rules as any other marketing surface:

• FTC claim rules apply (no deceptive claims, no unsubstantiated efficacy claims).
• FDA disease-claim rules apply.
• Endorsement Guides apply to any testimonials quoted in emails.
• State healthcare marketing rules apply.

Specific email marketing patterns

Pattern 1: Treatment announcement emails

Emails announcing new services or treatments need to meet both HIPAA marketing rules (if PHI is used) and claim compliance rules.

Pattern 2: Patient appointment follow-up

Appointment-specific communications are generally treatment-related. Emails that combine appointment follow-up with promotional content for additional services may cross into marketing.

Pattern 3: Patient testimonial emails

Newsletters featuring patient testimonials combine HIPAA authorization requirements, FTC Endorsement Guides requirements, and standard email compliance.

Pattern 4: Health education content

Genuinely educational content is generally lower-risk than promotional content. The line is whether the email is primarily education vs primarily promotion.

Pattern 5: Review solicitation emails

Post-visit emails soliciting reviews have specific considerations: FTC review-gating rules prohibit soliciting only happy patients; CAN-SPAM rules apply; HIPAA authorization for using patient information to solicit may be required.

Pattern 6: Appointment reminder emails

Typically treatment-related (not marketing under HIPAA). But if the reminder includes promotional content about other services, the promotional portion is marketing.

Patient list management

Email list management has specific healthcare considerations:

• Acquiring email addresses during treatment encounters - specific consent for marketing use beyond treatment communications.
• Third-party list purchases - generally not appropriate for healthcare.
• Opt-in from website forms - should clearly indicate marketing use.
• Opt-out processing - within CAN-SPAM timeframes, with appropriate HIPAA-compliant handling.

Platform and service provider considerations

Email marketing platforms (Mailchimp, Constant Contact, HubSpot, etc.) handling patient information are Business Associates under HIPAA. Specific considerations:

• Business Associate Agreements required with platforms handling PHI.
• Platform-level security must be HIPAA-compliant.
• Some platforms market HIPAA-compliant service tiers; verify specifically.

Compliant healthcare email marketing framework

• Appropriate authorization for list use.Specific consent for marketing beyond treatment.
• HIPAA-compliant platform. BAA in place, appropriate security.
• CAN-SPAM compliance. Header accuracy, physical address, opt-out.
• Content compliance. Same FDA/FTC rules as other marketing surfaces.
• Separation of treatment and marketing.Clear distinction or appropriate framing.
• Review-solicitation compliance. No review-gating.

Frequently asked questions

Does every patient email need opt-in?

Treatment-related emails typically don’t require marketing opt-in. Marketing emails do - either under HIPAA marketing authorization rules or CAN-SPAM opt-in mechanics, depending on the email category.

Can I send health education emails to my patient list?

Generally yes, with appropriate consent and if the content is genuinely educational rather than primarily promotional. Pure education to an existing patient list is low-risk.

What about sending special offers to my patient list?

This is marketing under HIPAA and CAN-SPAM. Requires appropriate authorization, CAN-SPAM compliance, and content-level compliance.

Do I need a specific HIPAA-compliant email service?

If you’re handling PHI in emails, yes. BAA with the provider, appropriate security. Many mainstream providers offer HIPAA-compliant tiers.

What about SMS marketing alongside email?

SMS has its own rules (TCPA) plus HIPAA considerations. Same general framework with additional SMS-specific considerations (prior express written consent, opt-out mechanics, message frequency disclosure).

How do I handle unsubscribe requests?

Process within 10 business days per CAN-SPAM. Don’t add unsubscribes back to lists. Don’t require unreasonable steps to unsubscribe (no passwords, no account login for opt-out).